Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression

Alley, 1988, Feasibility of drug screening with panels of human-tumor cell-lines using a microculture tetrazolium assay, Cancer Res., 48, 589 Baur, 2006, Therapeutic potential of resveratrol: the in vivo evidence, Nat. Rev. Drug Discov., 5, 493, 10.1038/nrd2060 Carter, 2014, Resveratrol and cancer: focus on in vivo evidence, Endocr. Relat. Cancer, 21, R209, 10.1530/ERC-13-0171 Catalgol, 2012, Resveratrol: French paradox revisited, Front. Pharmacol., 3, 141, 10.3389/fphar.2012.00141 Ceballos, 2018, Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines, Toxicol. Lett., 289, 63, 10.1016/j.toxlet.2018.03.011 Chalkiadaki, 2015, The multifaceted functions of sirtuins in cancer, Nat. Rev. Cancer, 15, 608, 10.1038/nrc3985 Chao, 2017, Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity, Sci. Rep., 7, 3180, 10.1038/s41598-017-03635-7 Chen, 2013, SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3beta/beta-catenin signaling, Hepatology, 57, 2287, 10.1002/hep.26278 Choi, 2009, Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol, Die Pharmazie, 64, 49 Clément, 1998, Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells, Blood, 92, 996, 10.1182/blood.V92.3.996 Daitoku, 2011, Regulation of FoxO transcription factors by acetylation and protein-protein interactions, Biochimica et Biophysica Acta, 1813, 1954, 10.1016/j.bbamcr.2011.03.001 de Lorgeril, 2002, Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease, Cardiovascular Res., 54, 503, 10.1016/S0008-6363(01)00545-4 Doyle, 2003, Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2), Oncogene, 22, 7340, 10.1038/sj.onc.1206938 Doyle, 1998, A multidrug resistance transporter from human MCF-7 breast cancer cells, Proc. Natl. Acad. Sci. USA, 95, 15665, 10.1073/pnas.95.26.15665 Dunn, 2012, Emerging insights into the molecular and cellular basis of glioblastoma, Genes Dev., 26, 756, 10.1101/gad.187922.112 Efferth, 2008, Prediction of broad spectrum resistance of tumors towards anticancer drugs, Clin. Cancer Res., 14, 2405, 10.1158/1078-0432.CCR-07-4525 Efferth, 2003, Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines, Naunyn-Schmiedeberg's Arch. Pharmacol., 367, 56, 10.1007/s00210-002-0632-0 Eisenberg, 2016, Cardioprotection and lifespan extension by the natural polyamine spermidine, Nat. Med., 22, 1428, 10.1038/nm.4222 Firestein, 2008, The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth, PloS One, 3, e2020, 10.1371/journal.pone.0002020 Fischer, 2018, Prevention from radiation damage by natural products, Phytomed., 47, 192, 10.1016/j.phymed.2017.11.005 Frank, 2005, ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma, Cancer Res., 65, 4320, 10.1158/0008-5472.CAN-04-3327 Frye, 2000, Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins, Biochem. Biophys. Res. Commun., 273, 793, 10.1006/bbrc.2000.3000 Garvin, 2006, Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo, Cancer Lett., 231, 113, 10.1016/j.canlet.2005.01.031 Gatouillat, 2010, Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma, J. Cell. Biochem., 110, 893, 10.1002/jcb.22601 Ge, 2013, Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK, Biomed. Environ. Sci., 26, 902 Gertz, 2012, A molecular mechanism for direct sirtuin activation by resveratrol, PloS One, 7, e49761, 10.1371/journal.pone.0049761 Grbesa, 2015, Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients, PloS One, 10, 10.1371/journal.pone.0124670 Grozinger, 2001, Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening, J. Biol. Chem., 276, 38837, 10.1074/jbc.M106779200 Hall, 2009, Is resistance useless? Multidrug resistance and collateral sensitivity, Trends Pharmacol. Sci., 30, 546, 10.1016/j.tips.2009.07.003 Howitz, 2003, Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature, 425, 191, 10.1038/nature01960 Huang, 2007, Dynamic FoxO transcription factors, J. Cell Sci., 120, 2479, 10.1242/jcs.001222 Jang, 1997, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 275, 218, 10.1126/science.275.5297.218 Jellin, 2000, 1521 Kawanobe, 2012, Expression of human ABCB5 confers resistance to taxanes and anthracyclines, Biochem. Biophys. Res. Commun., 418, 736, 10.1016/j.bbrc.2012.01.090 Kromhout, 1999, On the waves of the Seven Countries Study: a public health perspective on cholesterol, Eur. Heart J., 20, 796, 10.1053/euhj.1998.1357 Kuete, 2016, Cytotoxicity of seven naturally occurring phenolic compounds towards multi-factorial drug-resistant cancer cells, Phytomed., 23, 856, 10.1016/j.phymed.2016.04.007 Kuete, 2017, Cytotoxicity and mode of action of a naturally occurring naphthoquinone, 2-acetyl-7-methoxynaphtho[2,3-b]furan-4,9-quinone towards multi-factorial drug-resistant cancer cells, Phytomed., 33, 62, 10.1016/j.phymed.2017.07.010 Lal, 2009, EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts, Mol. Cancer Therap., 8, 1751, 10.1158/1535-7163.MCT-09-0188 Le Page, 2005, EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells, Prostate, 65, 130, 10.1002/pros.20234 Lee, 2008, A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy, Proc. Natl. Acad. Sci. USA, 105, 3374, 10.1073/pnas.0712145105 Lin, 2012, Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy, Free Rad. Biol. Med., 52, 377, 10.1016/j.freeradbiomed.2011.10.487 Liu, 2009, The critical role of the class III histone deacetylase SIRT1 in cancer, Cancer Res., 69, 1702, 10.1158/0008-5472.CAN-08-3365 Liu, 2011, Cistrome: an integrative platform for transcriptional regulation studies, Genome Biol., 12, R83, 10.1186/gb-2011-12-8-r83 Mohan, 2014, Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma, BioMed Res. Int., 2014, 10.1155/2014/424239 Morselli, 2010, Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy, Cell Death Dis., 1, e10, 10.1038/cddis.2009.8 Mukherjee, 2009, EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma, Cancer Res., 69, 4252, 10.1158/0008-5472.CAN-08-4853 Mukherjee, 2010, Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action, Can. J. Physiol. Pharmacol., 88, 1017, 10.1139/Y10-082 Murakami, 2003, Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide-and interferon-γ-induced IκB degradation in RAW264. 7 macrophages, Cancer Lett., 195, 17, 10.1016/S0304-3835(03)00058-2 Nabekura, 2005, Effects of dietary chemopreventive phytochemicals on P-glycoprotein function, Biochem. Biophys. Res. Commun., 327, 866, 10.1016/j.bbrc.2004.12.081 Nagane, 1998, Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases, Proc. Natl. Acad. Sci. USA, 95, 5724, 10.1073/pnas.95.10.5724 Nakagawa, 2001, Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator, J. Cancer Res. Clin. Oncol., 127, 258, 10.1007/s004320000190 Paull, 1989, Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm, J. Natl. Cancer Inst., 81, 1088, 10.1093/jnci/81.14.1088 Pervaiz, 2003, Resveratrol: from grapevines to mammalian biology, FASEB J., 17, 1975, 10.1096/fj.03-0168rev Pfister, 2009, Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity, Mol. Cancer Therap., 8, 1878, 10.1158/1535-7163.MCT-09-0016 Quan, 2008, Reversal effect of resveratrol on multidrug resistance in KBv200 cell line, Biomed. Pharmacother., 62, 622, 10.1016/j.biopha.2008.07.089 Rajapakse, V.N., Luna, A., Yamade, M., Loman, L., Varma, S., Sunshine, M., Iorio, F., Sousa, F.G., Elloumi, F., Aladjem, M.I., 2018. Integrative analysis of pharmacogenomics in major cancer cell line databases using CellMinerCDB. bioRxiv, 292904. Reinhold, 2012, CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set, Cancer Res., 72, 3499, 10.1158/0008-5472.CAN-12-1370 Renaud, 1992, Wine, alcohol, platelets, and the French paradox for coronary heart disease, Lancet, 339, 1523, 10.1016/0140-6736(92)91277-F Rubinstein, 1990, Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines, J. Natl. Cancer Inst., 82, 1113, 10.1093/jnci/82.13.1113 Saeed, 2013, Collateral sensitivity in drug-resistant tumor cells, 187 Saeed, 2014, Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking, Phytomed., 21, 1525, 10.1016/j.phymed.2014.07.011 Saeed, 2015, Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant cancer cells, J. Ethnopharmacol., 174, 644, 10.1016/j.jep.2015.07.005 Schlachterman, 2008, Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model, Transl. Oncol., 1, 19, 10.1593/tlo.07100 Shinojima, 2003, Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme, Cancer Res., 63, 6962 Stagos, 2012, Chemoprevention of liver cancer by plant polyphenols, Food Chem. Toxicol., 50, 2155, 10.1016/j.fct.2012.04.002 Sugimoto, 2003, Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists, Mol. Cancer Therap., 2, 105 Tang, 2010, Sirt1 and cell migration, Cell Adhesion Migr., 4, 163, 10.4161/cam.4.2.10972 Ueda, 1986, The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein, Biochem. Biophys. Res. Commun., 141, 956, 10.1016/S0006-291X(86)80136-X Vaziri, 2001, hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase, Cell, 107, 149, 10.1016/S0092-8674(01)00527-X Villalba, 2012, Sirtuin activators and inhibitors, BioFactors, 38, 349, 10.1002/biof.1032 Weinstein, 1998, Fishing expeditions, Science, 282, 628, 10.1126/science.282.5389.627g Wheeler, 2010, Understanding resistance to EGFR inhibitors-impact on future treatment strategies, Nat. Rev. Clin. Oncol., 7, 493, 10.1038/nrclinonc.2010.97 Wosikowski, 1997, Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns, J. Natl. Cancer Inst., 89, 1505, 10.1093/jnci/89.20.1505 Yang, 2016, Resveratrol increases sirtuin 1 expression in peripheral blood mononuclear cells of premature infants and inhibits the oxidative stress induced by hyperoxia in vivo, Chin. J. Contemp. Pediatr., 18, 72 Yeung, 2004, Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase, EMBO J., 23, 2369, 10.1038/sj.emboj.7600244 Yewale, 2013, Epidermal growth factor receptor targeting in cancer: a review of trends and strategies, Biomaterials, 34, 8690, 10.1016/j.biomaterials.2013.07.100